Related Experiment Video

Updated: May 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Clinical characteristics and risk factors for peripartum cardiomyopathy

G Y Huang1, L Y Zhang, M A Long-Le

  • 1Department of Cardiology, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, P.R. China.

African Health Sciences
|October 16, 2012
PubMed

Insights

Peripartum cardiomyopathy (PPCM) risk factors include hypertension, respiratory infection, and elevated high-sensitive C-reactive protein (hs-CRP). Identifying these can aid in PPCM prevention and treatment strategies.

Area of Science:

  • Cardiology
  • Obstetrics
  • Public Health

Background:

  • Peripartum cardiomyopathy (PPCM) is a severe form of heart failure with potential mortality.
  • Understanding PPCM risk factors is crucial for effective prevention and management strategies.

Purpose of the Study:

  • To investigate the clinical characteristics of patients diagnosed with PPCM.
  • To identify significant risk factors associated with the development of PPCM.

Main Methods:

  • Echocardiography was employed to assess left ventricular ejection fraction (LVEF).
  • Blood biomarkers including troponin I (cTNI), high-sensitive C-reactive protein (hs-CRP), and NT-proBNP were quantified.
  • Patient data were collected within weeks following delivery.

Main Results:

  • PPCM patients were older, had higher blood pressure, and a greater incidence of respiratory infections compared to controls.
  • Elevated levels of leucocytes, hs-CRP, cTNI, and NT-proBNP were observed in PPCM patients.
  • Independent risk factors identified were elevated hs-CRP (OR=1.86), respiratory infection (OR=2.87), and hypertension (OR=1.68).

Conclusions:

  • Hypertension, respiratory infection, and elevated hs-CRP are associated with PPCM development.
  • These findings highlight key factors for PPCM pathogenesis in the studied population.
Abstract

Keywords:
C-reaction proteinhypertensioninflammationmortalityperipartum cardiomyopathy

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...